Beta Alanine Supplementation
Conditions
Keywords
Aerobic Performance, Beta Alanine, Supplementation
Brief summary
Randomized, controlled, double-blind, double-blind clinical trial, with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) and single-center, to measure the efficacy of a sustained release beta alanine on the aerobic performance efficacy in recreational cyclist
Detailed description
Subjects meeting the selection criteria will be randomly assigned to each of the study groups (investigational product dose 1 or dose 2, or placebo, depending on the group to which they have been assigned). The product to be consumed is beta alanine. Participants will consume the product for 30 days. They will have to take 4 intakes every three hours, being the first intake two hours after waking up. The study subjects will have to make 2 visits to the laboratory. At the first and last visit, their aerobic performance will be evaluated by an incremental test to exhaustion with gas analysis.
Interventions
DIETARY_SUPPLEMENTBeta Alanine high dose
Subjects should consume 4 intakes of 5 g of beta alanine every 3 hours each day.
DIETARY_SUPPLEMENTBeta Alanine low dose
Subjects should consume 4 intakes of 2,5 g of beta alanine every 3 hours each day.
DIETARY_SUPPLEMENTControl product
Subjects should consume 4 intakes of 2,5 g of wheat semolina every 3 hours each day.
Sponsors
Universidad Católica San Antonio de Murcia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Male cyclists with more than two years of cycling experience. * Perform tests without fatigue. * Road bike training at least twice a week.
Exclusion criteria
* Participants with chronic illness. * Have a long-term injury that prevents you from training in the previous month. * Inability to understand informed consent. * Have consumed beta alanine in the three years prior to the start of the study. * Consumption of other supplements that may alter performance.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Power | Change in performance after 30 days of product consumption | Measured using a cyclus 2 roller. |
| Distance | Change in performance after 30 days of product consumption | Measured using a cyclus 2 roller. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Aerobic threshold | It will be measured twice, once at baseline or at the end of the study after 30 days. | Through a stress test with gas analysis |
| Microcapillary blood | It will be measured twice, once at baseline or at the end of the study after 30 days. | This test provides biochemical variables (ABL90FLEX) with 70 ml of capillary blood. |
| Anaerobic treshold | It will be measured twice, once at baseline or at the end of the study after 30 days. | Through a stress test with gas analysis |
| Heart Rate | It will be measured twice, once at baseline or at the end of the study after 30 days. | The heart rate will be evaluated by means of a heart rate strap. |
| Fatigue | It will be measured twice, once at baseline or at the end of the study after 30 days. | Rate of perceived exertion |
| Lactate | It will be measured twice, once at baseline or at the end of the study after 30 days. | Lactate levels will be measured using the Lactate Pro 2 |
| Maximum oxygen consumption | It will be measured twice, once at baseline or at the end of the study after 30 days. | Through a stress test with gas analysis |
Countries
Spain
Outcome results
None listed